Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic riskJill Corre, Hervé Avet‐Loiseau, Karim Belhadj et al.|Haematologica|2019Cited by 90
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Bertrand Joly, Maxime Vallée et al.|Leukemia|2019Cited by 47
Lenalidomide Consolidation Improves Measurable Residual Disease (MRD) Rates and Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Following Initial FCR Chemotherapy - Final Analysis of CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)Thérèse Aurran‐Schleinitz, David Gottlieb, Stephen P. Mulligan et al.|Blood|2023Cited by 1